ArticleEuropean heart journal open2025

Remnant cholesterol concentrations best explain the cardiovascular benefit of APOC3 genetic inhibition: a drug target Mendelian randomization study.

Eloi Gagnon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.